Buy the dips in international stocks as US lead fades, says JPMorgan

JPMorgan urges investors to 'buy the dips' in international (non‑US) equities, saying the growth‑inflation mix remains supportive as earnings hold up, activity data are solid, inflation is softening and long‑dated yields have drifted lower. International markets outperformed the US by 12% in 2025 and lead by about 8% year‑to‑date in 2026; strategists expect leadership to broaden away from concentrated Mag‑7 tech toward small caps, value and non‑US stocks, while flagging that geopolitical risks around Iran and tariff headlines may trigger short‑lived pullbacks that should be treated as buying opportunities.

Analysis

Market structure: The immediate winners are non‑US equities (Europe, Japan, EM), small caps and value/cyclicals — sectors with greater earnings leverage to a steady growth/softening‑inflation mix — while concentrated US Mag‑7 tech is the obvious loser if leadership fails to reassert. The 12% 2025 international outperformance and +8% YTD 2026 momentum signal active reallocation; lower long yields and Fed‑easing odds compress discount rates more for cyclicals than for hyper‑growth stocks. Cross‑asset: expect a modestly weaker USD, upward pressure on oil and gold during geopolitical blips, and equity‑friendly carry in FX and credit spreads tightening if risk premium falls.

Risk assessment: Tail risks include a sharp Iran escalation (shipping attacks, energy shocks), an aggressive US tariff escalation hitting exporters, or a Fed backtrack if inflation surprises higher — each could trigger >10% regional drawdowns within days. Immediate (days) risks are volatility spikes and flow reversals; medium term (1–3 months) is leadership consolidation if earnings surprise; long term (3–12 months) depends on whether Mag‑7 regains valuation premium. Hidden dependencies: passive ETF rebalancings, hedging costs (FX hedges erode EM/Europe returns), and corporate buyback cadence.

Trade implications: Tactical overweight non‑US via ETFs and cyclical sectors, funded by trimming mega‑cap tech: use IEFA/VGK/EWJ/EEM for broad exposure and IJR for US small‑caps; execute pair trades long IEFA short QQQ to isolate regional beta. Options: buy 3‑month call spreads on EEM/VGK 10–15% OTM after 3–7% pullbacks and hold 6–12 weeks; buy short‑dated put spreads on SPY (‑5% to ‑8%) sized as 0.5–1% portfolio tail hedge.

Contrarian angles: The consensus underestimates how fast Mag‑7 could reassert leadership if AI revenues or buybacks accelerate — a 5–10% reversal in 6–12 weeks is plausible, which would punish long international/ small‑cap positioning. European/Japanese cyclicals still look oversold relative to normalized EPS (20–30% cheap vs US on P/E), but tariff escalation or USD strength could flip that thesis quickly; risk/reward is asymmetric — size positions 1–3% and use tight risk controls.

Key Decisions for Investors

• Establish a 2–3% portfolio long in IEFA (or VGK+EWJ split) over 4–8 weeks, scaling on 3–7% regional pullbacks; target +10–15% total return in 3–6 months, stop‑loss at -8% or if US 10y > 3.8% sustained for 10 trading days.
• Implement a 1.5% long IJR / 1.5% short QQQ pair (size to portfolio) to capture small‑cap vs mega‑cap rotation over 3 months; unwind if the IJR/QQQ spread narrows by 5% or if QQQ outperforms by 7% in 30 days.
• Buy a 3‑month EEM 10–15% OTM call spread sized to 0.5–1% of portfolio as convex exposure to a risk‑on continuation; simultaneously purchase a 3‑month SPY 5–8% OTM put spread (0.5–1% portfolio) as geopolitical tail insurance.
• Trim US mega‑cap exposure by 3–5% (reduce QQQ/SPY holdings) and reallocate to international cyclicals/financials; reassess after next two US/ECB policy statements and the next full earnings season (6–8 weeks).